Euclidean Capital as of June 30, 2025
Portfolio Holdings for Euclidean Capital
Euclidean Capital holds 11 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Intl Equity Index F Allwrld Ex Us (VEU) | 47.1 | $144M | 2.1M | 67.22 | |
| Ishares Tr Msci India Etf (INDA) | 44.2 | $135M | 2.4M | 55.68 | |
| Oric Pharmaceuticals (ORIC) | 3.3 | $10M | 989k | 10.15 | |
| Foghorn Therapeutics (FHTX) | 2.4 | $7.4M | 1.6M | 4.70 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $2.8M | 2.6M | 1.06 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.8 | $2.5M | 4.1k | 617.85 | |
| Alector (ALEC) | 0.6 | $1.8M | 1.3M | 1.40 | |
| Surrozen Com New (SRZN) | 0.3 | $784k | 88k | 8.94 | |
| Rapt Therapeutics Com New (RAPT) | 0.2 | $658k | 82k | 8.00 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $621k | 1.0M | 0.61 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.1k | 171k | 0.02 |
